Diabetes, Metabolic Syndrome and Obesity (Aug 2023)
Is Metabolic Score for Visceral Fat (METS-VF) a Better Index Than Other Adiposity Indices for the Prediction of Visceral Adiposity
Abstract
Cundullah Torun,1 Handan Ankaralı,2 Lütfullah Caştur,1 Mehmet Uzunlulu,1 Ayşe Naciye Erbakan,1 Muhammet Mikdat Akbaş,1 Nesrin Gündüz,3 Mahmut Bilal Doğan,3 Aytekin Oğuz1 1Department of Internal Medicine, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Kadikoy, Istanbul, Türkiye; 2Department of Biostatistics and Medical Informatics, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Kadikoy, Istanbul, Türkiye; 3Department of Radiology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Kadikoy, Istanbul, TürkiyeCorrespondence: Cundullah Torun, Goztepe Training and Research Hospital, District of Kadıköy, Neighbourhood of Eğitim, Kadikoy, Province of Istanbul, 34722, Türkiye, Tel +905497949993, Fax +90 216 606 52 10, Email [email protected]: Visceral adiposity is an important risk factor for cardiometabolic diseases.Objective: To determine whether the Metabolic Score for Visceral Fat (METS-VF) is more effective than other adiposity indices in predicting visceral fat area (VFA).Methods: In this single-center and cross-sectional study, we included patients aged 20– 50 years, without diabetes and coronary artery disease, who underwent computed tomography (CT) including the third lumbar vertebra. Age, blood pressure, waist circumference (WC), hip circumference, fasting lipids, and glucose were assessed. VFA was measured by cross-sectional examination of CT. The correlation of WC, body mass index (BMI), waist-hip ratio (WHR), lipid accumulation product (LAP), visceral adiposity index (VAI), a body shape index (ABSI), body roundness index (BRI), and METS-VF with VFA was analyzed by correlation analysis. The cut-off values and area under the curve (AUC) for identifying increased VFA (> 130 cm2) were determined.Results: We included 185 individuals with mean age 38.2 ± 8 and female predominance (58.4%). There was a significant positive correlation between all indices and VFA (p 6.4 in males > 6.5 in females and WC cut-off point > 88 cm in males (AUC 0.922), > 90.5 cm in females (AUC 0.938).Conclusion: METS-VF is strongly associated with visceral adiposity and better to predict increased VFA. However, its superiority over WC, BMI, BRI, and LAP was not significant. The results emphasize that WC is more appealing as screening indicator for visceral adiposity considering its easy use.Clinical Trial Registry Name: Clinicaltrials.gov (http://www.clinicaltrials.gov).Clinical Trial Registry Url: https://clinicaltrials.gov/ct2/show/NCT05648409.Clinical Trial Registry Number: NCT05648409.Keywords: obesity, cardiometabolic risk, hypertriglyceridemic waist, body shape, anthropometric measurements
